Stock A291650 APTAMER SCIENCES INC
Add to a list
To use this feature you must be a member
Log inSign up

News Aptamer Sciences Inc

Equities

A291650

KR7291650000

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-15 pm EDT 		5-day change 1st Jan Change
2,815 KRW -2.76% Intraday chart for Aptamer Sciences Inc -6.17% -21.91%
Mar. 26 Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201 CI
2022 Aptamer Sciences Inc announced that it has received KRW 16.5 billion in funding from a group of investors CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201
CI
Aptamer Sciences Inc announced that it has received KRW 16.5 billion in funding from a group of investors
CI
Aptamer Sciences Inc announced that it expects to receive KRW 16.5 billion in funding from a group of investors
CI
Aptamer Sciences Inc(KOSDAQ:A291650) dropped from S&P Global BMI Index
CI
Aptamer Sciences Inc.(KOSDAQ:A291650) added to S&P Global BMI Index
CI
Aptamer Sciences Inc. has completed an IPO in the amount of KRW 32.5 billion.
CI
Aptamer Sciences Inc. has filed an IPO.
CI
Aptamer Sciences Inc. has withdrawn its IPO in the amount of KRW 23.4 billion.
CI
Aptamer Sciences Inc. has filed an IPO.
CI
Aptamer Sciences, Inc. announced that it expects to receive $7.3 million in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A291650 Stock
  4. News Aptamer Sciences Inc